The 1 analysts offering 12-month price forecasts for Baudax Bio Inc have a median target of 3.25, with a high estimate of 3.25 and a low estimate of 3.25. The median estimate represents a +347.17% increase from the last price of 0.73.
The current consensus among 1 polled investment analysts is to Buy stock in Baudax Bio Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.72
Reporting Date Nov 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.